Needle Stimulator (SDZ-IIB, SDZ-IIC, SDZ-III, SDZ-V)
Suzhou Medical Appliance Factory · Decision date Oct 22, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 22, 2026 for K260230, a traditional 510(k) submitted by Suzhou Medical Appliance Factory for the Needle Stimulator family (SDZ-IIB, SDZ-IIC, SDZ-III, SDZ-V), product code BWK. The submission lists Wuxi Jiajian Medical Instrument Co., Ltd.'s Needle Stimulator CMNS6-1 (K202861) as predicate. SESE means clearance to market, not PMA approval. The summary states the four models share intended use and operating principle, differing in output channels (two for SDZ-IIB, six for the others), display, controls and stimulation timing.
The stated indication is use in acupuncture practice by qualified practitioners as determined by the states, for adults aged 22 and older. The summary describes low-frequency pulses delivered to acupuncture needles through lead wires and alligator connectors, with Type BF isolation. The public record does not include the full 20-page summary, so performance testing, electrical safety detail and labeling remain unverified here; the specialty field is listed as Unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Oct 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260230
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Suzhou Medical Appliance Factory
- Product code
- BWK
- Decision code
- SESE
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Electro-Acupuncture.
- Applicant
- Suzhou Medical Appliance Factory
- Product code
- BWK
- FDA device class
- U
FDA decision timeline
K260230 received
Application receipt date recorded by FDA.
K260230 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Suzhou Medical Appliance Factory
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suzhou
Sources and methodology
- Original FDA record: K260230
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records